BlueLinx Holdings Inc.
NYSE:BXCConstruction
+$4.26 today
- Market cap
- $464.79M
- Beta
- 1.45
- P/E (TTM)
- -114.4
- EPS (TTM)
- -$0.51
Volume 0.12M
Average 0.13M
BXC Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
BlueLinx Holdings Inc.NYSE: BXC
Capital Expenditures · Q1 FY2026 · quarter ended Apr 2026
Capital expenditures declines year over year
Q1 FY2026 capital expenditures of $2.6M (cash outflow) fell 56.2% year over year, behind the -41.9% change in trailing-twelve-month capital expenditures. Sequentially, it fell 52.3% from the prior quarter. Over 3 fiscal years it compounded at -9.1% a year.
Context
- Capital expenditures amounted to 0.9% of revenue in FY2025, down 0.4 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -56.2% toward the trailing-twelve-month pace of -41.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (26.93M) USD
- Year-over-year change
- +32.9%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | (26.93M) | +32.9% |
| FY2024 | 2024-12-28 | (40.11M) | -45.7% |
| FY2023 | 2023-12-31 | (27.52M) | +23.3% |
| FY2022 | 2022-12-31 | (35.89M) | -148.9% |
| FY2021 | 2021-12-31 | (14.42M) | — |
Capital Expenditures vs competitors
How BXC compares with its peers on the latest reported figures
- BXC's LTM Apr 2026 capital expenditures of $23.6M is the 6th largest of the 9 companies compared; the peer median is $31.07M.
- Its year-over-year change of -41.9% is the 7th highest of 9, against a peer median of -4.4%.
- Capital expenditures amounts to 0.8% of revenue for BXC, versus a peer median of 3.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $124.31M | +147.7% | +216.5% | 38.4% | |
| LTM Mar 2026 | $113.03M | -34.7% | +12.9% | 3.6% | |
| LTM Apr 2026 | $58.42M | +25.8% | +23.7% | 3.1% | |
| LTM Mar 2026 | $36.32M | -41.5% | -9.7% | 2.0% | |
| LTM Mar 2026 | $25.82M | -64.8% | -40.5% | 11.2% | |
| LTM Apr 2026 | $23.6M | -41.9% | -9.1% | 0.8% | |
| LTM Mar 2026 | $22.06M | +116.0% | +13.7% | 1.8% | |
| LTM Mar 2026 | $9.77M | +39.6% | -12.3% | 5.5% | |
| LTM Mar 2026 | $4.99M | -43.9% | -1.2% | 2.5% | |
| Peer median (excluding BXC) | $31.07M | -4.4% | +5.9% | 3.4% | |
Competitors are the stored peer set for BXC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | 296.13M | 296.18M | 48.54M | 53.12M | 219K |
| Depreciation & Amortization | 28.19M | 27.61M | 32.04M | 38.49M | 39.91M |
| Deferred Income Tax | 356K | 5.29M | 7.76M | 2.68M | (36K) |
| Stock-Based Compensation | 6.59M | 9.62M | 12.06M | 7.75M | 11.25M |
| Change in Working Capital | (182.69M) | 64.53M | 178.98M | (13.97M) | 13.31M |
| Accounts Receivables | (45.99M) | 101.27M | 23.15M | 2.57M | 14.05M |
| Inventory | (146.35M) | 20.76M | 140.88M | (12.27M) | 45.96M |
| Accounts Payables | 14.84M | (31.81M) | 5.97M | 13M | (36.01M) |
| Other Working Capital | (5.18M) | (25.69M) | 8.99M | (17.27M) | (10.69M) |
| Other Non-Cash Items | (3.56M) | (2.93M) | 26.92M | (2.89M) | (4.87M) |
| Operating Cash Flow | 145.02M | 400.3M | 306.29M | 85.18M | 59.78M |
| Capital Expenditures | (14.42M) | (35.89M) | (27.52M) | (40.11M) | (26.93M) |
| Acquisitions (Net) | 0 | (63.77M) | 300K | 0 | (92.55M) |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 10.33M | 964K | 357K | (39.21M) | 0 |
| Investing Cash Flow | (4.09M) | (98.69M) | (26.86M) | (39.21M) | (119.49M) |
| Debt Repayment | (45.16M) | (10.91M) | (9.21M) | (13.43M) | (16.32M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (5.19M) | (76.96M) | (47.41M) | (48.66M) | (40.66M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (5.46M) | 0 | 0 | 0 | (3.1M) |
| Financing Cash Flow | (55.81M) | (87.87M) | (56.62M) | (62.09M) | (60.08M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 85.12M | 213.74M | 222.8M | (16.12M) | (119.78M) |
| Free Cash Flow | 130.61M | 364.41M | 278.77M | 45.07M | 32.85M |
BlueLinx Holdings Inc.
NYSE:BXC
Intrinsic Alpha fair value
Locked
Current Price
$59.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.